New hope for kidney patients: diabetes drugs tested to fight nephrotic syndrome

This study tests whether two diabetes drugs (dapagliflozin and empagliflozin) can help adults with nephrotic syndrome, a kidney condition that causes protein leakage and swelling. About 75 participants will receive either one of these drugs plus standard care, or standard care alone, for 6 months. The goal is to see if these drugs reduce protein in urine, maintain remission, and prevent relapse, while monitoring kidney function and side effects.